IHVN set to launch a Campus of Excellence in Public Health Implementation, Training and Research in Nigeria.

———-Professor Robert Gallo, Globally Acclaimed Co-Discoverer of HIV expected to grace the

occasion among other dignitaries

The Institute of Human Virology Nigeria (IHVN) has announced it will
officially launch its state-of-the-art multi-campus of excellence in public healthcare, treatment
training, and research to bring quality health services within the reach of millions of Nigerians.
The IHVN Campus, located on Plot 62, Emeritus Umaru Shehu Avenue, Cadastral Zone, COO, Abuja,
is a combination of leasable office buildings, clinical laboratories for diagnosis, research, and
training, functional clinic spaces for patient care and clinical trials, bio-specimen repositories for
storage and management of bio-specimens, multi-media lecture auditoriums and meeting rooms
and offices.
The event, which will take place on June 6, will be preceded by a scientific seminar on addressing
local health challenges through quality research and partnership. The seminar will bring together
key scientists and public-private stakeholders in the health sector with Professor Robert Gallo,
Director, Institute of Human Virology, Baltimore USA; Professor Alash’le Abimiku, Executive
Director, International Research Center of Excellence (IRCE), and Dr. Ifedayo Morayo Adetifa,
Director General of Nigerian Center for Disease Control (NCDC) as the main speakers.
As an internationally recognized local and nonprofit organization, IHVN is structured to develop and
maintain linkages with other local and international organizations, in collaborative ways that
support the Government of Nigeria’s health sector strategic plans. IHVN focuses on the prevention,
treatment, and management of diseases such as HIV/AIDS, TB, malaria, COVID-19, Cancer, and other
infectious and non-infectious diseases.
Speaking about the development, the Chief Executive Officer of the Institute of Human Virology of
Nigeria, Dr. Patrick Dakum, says "The commissioning of the IHVN Campus demonstrates the
Institute’s commitment as a leader in providing health service implementation, capacity building,
research and ensuring equitable access to quality healthcare services through innovative and
evidence-based strategies.” Dr. Dakum also says that with its two centers now on campus: the
Program Implementation Center (PIC) and the International Research Center of Excellence, the
Institute will continue to develop training and expertise for the sustainability of HIV/AIDS, TB,
Malaria, and Cancer programs.
The commissioning of the IHVN Campus is expected to revolutionize the fight against emerging
infectious and non-infectious diseases in Nigeria and the African Continent.